Global Antidiabetic SGLT-2 Inhibitor Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook - 2019-2027

Date: May 12 2020
|
AllTheResearch (Featured Publisher)
|
Number of Pages: 135
|
Alternate Text Alternate Text Alternate Text Alternate Text
Category: Pharma & Healthcare

The global antidiabetic sglt-2 inhibitor market was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by the end of the forecast period, growing at a CAGR of XX% during the period from 2020 to 2027.

The research report segments the market from a relevancy perspective into the below segments and sub-segments with quantitative analysis done from 2019 to 2027 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2020 to 2027 to provide a reference for growth potential.

Market Segments and Sub-segments Covered in the Report:

Based on Product Type antidiabetic sglt-2 inhibitor market is segmented into:
Canagliflozin
Empagliflozin
Dapagliflozin
Other

Based on Application antidiabetic sglt-2 inhibitor market is segmented into:
Hospitals
Clinics
Other

Based on Geography antidiabetic sglt-2 inhibitor market is segmented into:
North America (U.S. and Canada)
Europe (U.K., Germany, France, Spain, Italy and Rest of Europe)
Asia Pacific (China, Japan, India, Indonesia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

Key Market Players Analysed and Profiled in the Study Include:
Pfizer
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb

This report covers an in-depth analysis of the antidiabetic sglt-2 inhibitor market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of antidiabetic sglt-2 inhibitor market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

Key Questions answered in the Report:

• What is the size of the overall antidiabetic sglt-2 inhibitor market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the antidiabetic sglt-2 inhibitor market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Market?
• What is the antidiabetic sglt-2 inhibitor market size at the regional and country level?
• Who are the key market players and their key competitors?
• Market value- chain and key trends impacting every node with reference to companies
• What are the strategies for growth adopted by the key players in antidiabetic sglt-2 inhibitor market?
• How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization?
• How financially strong are the key players in antidiabetic sglt-2 inhibitor market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)?
• What are the recent trends in antidiabetic sglt-2 inhibitor market? (M&A, partnerships, new product developments, expansions)

Years Considered During the Study:

Historical Year: 2017 and 2018
Base Year: 2019
Forecast Period: 2020 to 2027

Chapter 1 Preface
   1.1 Report Description
          1.1.1 Purpose of the Report
          1.1.2 Target Audience
          1.1.3 USP and Key Offerings
   1.2 Research Scope
   1.3 Research Methodology
          1.3.1 Secondary Research
          1.3.2 Primary Research
          1.3.3 Expert Panel Review
          1.3.4 Approach Adopted
                1.3.4.1 Top-Down Approach
                1.3.4.2 Bottom-Up Approach
          1.3.5 Assumptions
   1.4 Market Segmentation Scope
Chapter 2 Executive Summary
   2.1 Market Summary
          2.1.1 Global Antidiabetic SGLT-2 Inhibitor Market, 2017-2027, (US$ Mn)
   2.2 Market Snapshot: Global Antidiabetic SGLT-2 Inhibitor Market
          2.2.1 Market Dynamics (DRO)
   2.3 Global Antidiabetic SGLT-2 Inhibitor Market, by Segment, 2019
          2.3.1 Global Antidiabetic SGLT-2 Inhibitor Market, by Region, 2019 (US$ Mn)
          2.3.2 Global Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2019 (US$ Mn)
          2.3.3 Global Antidiabetic SGLT-2 Inhibitor Market, by Application, 2019 (US$ Mn)
   2.4 Premium Insights
          2.4.1 Market In Developed Vs. Developing Economies, 2019 vs 2027
          2.4.2 Market Regional Life Cycle Analysis
          2.4.3 Pricing Analysis, by Region
                2.4.3.1 Pricing by Product
                2.4.3.2 Pricing by Applications
                2.4.3.3 Pricing by Geography/Regions
          2.4.4 Technological Integrations
          2.4.5 Supply Chain Analysis and Vendor Landscaping
          2.4.6 Emerging Player Analysis
          2.4.7 Major Investments in Market
          2.4.8 Mega Trend Analysis
          2.4.9 Regulatory Analysis
          2.4.10 Key Factors Influencing Purchasing/Buying Decisions
          2.4.11 Market Pain-Points and Unmet Needs
          2.4.12 Key Stakeholder analysis (patients, physicians, competition and more)
Chapter 3 Market Dynamics
   3.1 Market Overview
   3.2 Market Driver, Restraint and Opportunity Analysis
   3.3 Market Ecosystem Analysis
   3.4 Market Trends Analysis
   3.5 Industry Value Chain Analysis
   3.6 Market Analysis
          3.6.1 SWOT Analysis
          3.6.2 Porter's 5 Forces Analysis
   3.7 Analyst Views
Chapter 4 Global Antidiabetic SGLT-2 Inhibitor Market, by Product Type
   4.1 Market Overview, by Product Type
          4.1.1 Incremental Opportunity, by Product Type, 2019-2027

Canagliflozin
Empagliflozin
Dapagliflozin
Other
Chapter 5 Global Antidiabetic SGLT-2 Inhibitor Market, by Application
   5.1 Market Overview, by Application
          5.1.1 Incremental Opportunity, by Application, 2019-2027

Hospitals
Clinics
Other
Chapter 6 Global Antidiabetic SGLT-2 Inhibitor Market, by Region
   6.1 Market Overview, by Region
          6.1.1 Global Antidiabetic SGLT-2 Inhibitor Market, by Region, 2017-2027, (US$ Mn)
   6.2 Incremental Opportunity, by Region, 2019
   6.3 North America Antidiabetic SGLT-2 Inhibitor Market
          6.3.1 North America Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
          6.3.2 North America Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
          6.3.3 North America Antidiabetic SGLT-2 Inhibitor Market, by Country, 2017-2027 (US$ Mn)
                6.3.3.1 U.S.
                   6.3.3.1.1 U.S. Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.3.3.1.2 U.S. Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.3.3.2 Canada
                   6.3.3.2.1 Canada Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.3.3.2.2 Canada Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
   6.4 Europe Antidiabetic SGLT-2 Inhibitor Market
          6.4.1 Europe Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
          6.4.2 Europe Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
          6.4.3 Europe Antidiabetic SGLT-2 Inhibitor Market, by Country, 2017-2027 (US$ Mn)
                6.4.3.1 U.K.
                   6.4.3.1.1 U.K. Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.1.2 U.K. Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.2 Germany
                   6.4.3.2.1 Germany Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.2.2 Germany Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.3 France
                   6.4.3.3.1 France Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.3.2 France Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.4 Italy
                   6.4.3.4.1 Italy Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.4.2 Italy Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.5 Spain
                   6.4.3.5.1 Spain Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.5.2 Spain Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.4.3.6 Rest of Europe
                   6.4.3.6.1 Rest of Europe Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.4.3.6.2 Rest of Europe Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
   6.5 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market
          6.5.1 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
          6.5.2 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
          6.5.3 Asia Pacific Antidiabetic SGLT-2 Inhibitor Market, by Country, 2017-2027 (US$ Mn)
                6.5.3.1 China
                   6.5.3.1.1 China Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.1.2 China Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.2 India
                   6.5.3.2.1 India Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.2.2 India Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.3 Japan
                   6.5.3.3.1 Japan Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.3.2 Japan Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.4 Indonesia
                   6.5.3.4.1 Indonesia Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.4.2 Indonesia Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.5.3.5 Rest of Asia Pacific
                   6.5.3.5.1 Rest of Asia Pacific Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.5.3.5.2 Rest of Asia Pacific Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
   6.6 Latin America Antidiabetic SGLT-2 Inhibitor Market
          6.6.1 Latin America Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
          6.6.2 Latin America Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
          6.6.3 Latin America Antidiabetic SGLT-2 Inhibitor Market, by Country, 2017-2027 (US$ Mn)
                6.6.3.1 Brazil
                   6.6.3.1.1 Brazil Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.1.2 Brazil Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.6.3.2 Mexico
                   6.6.3.2.1 Mexico Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.2.2 Mexico Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.6.3.3 Rest of Latin America
                   6.6.3.3.1 Rest of Latin America Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.6.3.3.2 Rest of Latin America Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
   6.7 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market
          6.7.1 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
          6.7.2 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
          6.7.3 Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market, by Region/Country, 2017-2027 (US$ Mn)
                6.7.3.1 GCC
                   6.7.3.1.1 GCC Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.1.2 GCC Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.7.3.2 South Africa
                   6.7.3.2.1 South Africa Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.2.2 South Africa Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
                6.7.3.3 Rest of Middle East & Africa
                   6.7.3.3.1 Rest of Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market, by Product Type, 2017-2027 (US$ Mn)
                   6.7.3.3.2 Rest of Middle East & Africa Antidiabetic SGLT-2 Inhibitor Market, by Application, 2017-2027 (US$ Mn)
Chapter 7 Competitive Intelligence
   7.1 Market Players Present in Market Life Cycle
   7.2 Key Player Analysis
   7.3 Market Positioning
   7.4 Market Players Mapping, vis-à-vis Ecosystem
          7.4.1 By Segments
          7.4.2 By Region
   7.5 Strategies Adopted by Key Market Players
   7.6 Recent Developments in the Market
          7.6.1 Organic (New Product Launches, R&D, Financial, Technology)
          7.6.2 Inorganic (Mergers & Acquisitions, Partnership and Alliances, Fund Raise)
Chapter 8 Company Profiles - with focus on Company Fundamentals, Product Portfolio, Financial Analysis, Recent News and Developments, Key Strategic Instances, SWOT Analysis

Pfizer
AstraZeneca
Johnson & Johnson
GlaxoSmithKline
Merck & Co
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Chapter 9 About Us

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.